A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03933735 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03933735
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2026-05-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.